comparemela.com
Home
Live Updates
Scancell melanoma trial continues to yield 'excellent result
Scancell melanoma trial continues to yield 'excellent result
Scancell melanoma trial continues to yield 'excellent results'
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said a further two people from a group of hard-to-treat melanoma patients in its SCOPE study have responded to...
Related Keywords
Lindy Durrant ,
Scancell Holdings ,